Comments
Loading...
Altimmune Earnings Estimates, EPS & Revenue | NASDAQ:ALT | Benzinga
Altimmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.380
Quarterly Revenue Estimate
$1.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$20.00K
Analyze the earnings history of Altimmune using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALT | Altimmune | -$0.34 | -$0.38 | — | — | $5.00K | $1.00K | — | — | 05/08/2025 | Get Alert |
| ALT | Altimmune | -$0.54 | -$0.34 | -$0.33 | 2.94% | $37.00K | — | $5.00K | — | 02/27/2025 | Get Alert |
| ALT | Altimmune | -$0.39 | -$0.35 | -$0.32 | 8.57% | $362.00K | — | $5.00K | — | 11/12/2024 | Get Alert |
| ALT | Altimmune | -$0.32 | -$0.34 | -$0.35 | -2.94% | $6.00K | — | $5.00K | — | 08/08/2024 | Get Alert |
| ALT | Altimmune | -$0.40 | -$0.37 | -$0.34 | 8.11% | $21.00K | — | $5.00K | — | 05/09/2024 | Get Alert |
| ALT | Altimmune | -$0.43 | -$0.43 | -$0.33 | 23.26% | -$110.00K | — | $37.00K | — | 03/27/2024 | Get Alert |
| ALT | Altimmune | -$0.48 | -$0.42 | -$0.39 | 7.14% | $2.00K | — | $362.00K | — | 11/07/2023 | Get Alert |
| ALT | Altimmune | -$0.42 | -$0.46 | -$0.32 | 30.43% | $8.00K | — | $6.00K | — | 08/10/2023 | Get Alert |
| ALT | Altimmune | -$0.44 | -$0.48 | -$0.40 | 16.67% | $32.00K | — | $21.00K | — | 05/11/2023 | Get Alert |
| ALT | Altimmune | -$0.57 | -$0.50 | -$0.43 | 14.00% | $3.28M | $30.00K | -$110.00K | -466.67% | 02/28/2023 | Get Alert |
| ALT | Altimmune | -$0.81 | -$0.50 | -$0.48 | 4.00% | $200.00K | $870.00K | $2.00K | -99.77% | 11/10/2022 | Get Alert |
| ALT | Altimmune | -$0.41 | -$0.51 | -$0.42 | 17.65% | $137.62K | $870.00K | $8.00K | -99.08% | 08/11/2022 | Get Alert |
| ALT | Altimmune | -$0.38 | -$0.58 | -$0.44 | 24.14% | $837.52K | $1.03M | $32.00K | -96.89% | 05/12/2022 | Get Alert |
| ALT | Altimmune | -$0.17 | -$0.65 | -$0.57 | 12.31% | $2.31M | $90.00K | $3.28M | 3542.22% | 03/15/2022 | Get Alert |
| ALT | Altimmune | -$0.54 | $0.39 | -$0.81 | -307.69% | $2.94M | $60.00K | $200.00K | 233.33% | 11/09/2021 | Get Alert |
| ALT | Altimmune | -$0.94 | -$0.50 | -$0.41 | 18.00% | $721.64K | $1.84M | $137.62K | -92.52% | 08/10/2021 | Get Alert |
| ALT | Altimmune | -$0.26 | -$0.47 | -$0.38 | 19.15% | $2.21M | — | $837.52K | — | 05/17/2021 | Get Alert |
| ALT | Altimmune | -$0.25 | -$0.75 | -$0.17 | 77.33% | $575.80K | $2.14M | $2.31M | 8.08% | 02/25/2021 | Get Alert |
| ALT | Altimmune | -$0.74 | -$0.76 | -$0.54 | 28.95% | $643.98K | $1.05M | $2.94M | 179.81% | 11/09/2020 | Get Alert |
| ALT | Altimmune | -$0.26 | -$0.40 | -$0.94 | -135.00% | $1.63M | $1.10M | $721.64K | -34.40% | 08/11/2020 | Get Alert |
| ALT | Altimmune | -$0.27 | -$0.32 | -$0.26 | 18.75% | $2.96M | $500.00K | $2.21M | 342.60% | 05/13/2020 | Get Alert |
| ALT | Altimmune | -$0.02 | -$0.26 | -$0.25 | 3.85% | $2.59M | $750.00K | $575.80K | -23.23% | 03/27/2020 | Get Alert |
Altimmune (ALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.33 | $-0.34 | 2.94 % |
| Q3 | 2024-11-12 | $-0.32 | $-0.35 | 8.57 % |
| Q2 | 2024-08-08 | $-0.35 | $-0.34 | -2.94 % |
| Q1 | 2024-05-09 | $-0.34 | $-0.37 | 8.11 % |
Altimmune (ALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-02-28 | $-110.00K | $30.00K | -466.7 % |
| Q3 | 2022-11-10 | $2.00K | $870.00K | -99.8 % |
| Q2 | 2022-08-11 | $8.00K | $870.00K | -99.1 % |
| Q1 | 2022-05-12 | $32.00K | $1.03M | -96.9 % |
FAQ
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune (ALT) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Altimmune (NASDAQ:ALT)?
The Actual EPS was $-0.33, which beat the estimate of $-0.34.
What were Altimmune’s (NASDAQ:ALT) revenues?
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.